Quantitative Stratification of Diffuse Parenchymal Lung Diseases

• Sushravya Raghunath,

  Affiliation Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Srinivasan Rajagopalan,

  Affiliation Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Ronald A. Karwoski,

  Affiliation Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Fabien Maldonado,

  Affiliation Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Tobias Peikert,

  Affiliation Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Teng Moua,

  Affiliation Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Jay H. Ryu,

  Affiliation Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Brian J. Bartholmai,

  Affiliation Department of Radiology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Richard A. Robb

  * E-mail: robb.richard@mayo.edu

  Affiliation Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯